Edgar Tracker

HOWL Werewolf Therapeutics, Inc.

Nasdaq · CIK 1785530 · Pharmaceutical Preparations

SEC company page

Public articles

No public articles yet. Follow HOWL to track filings and write notes.

Recent filings

–

Form Filed Title Accession
S-4/A2026-10-26REGISTRATION OF SECURITIES ISSUED IN BUSINESS COMBINATION TRANSACTIONS0001140361-26-040784
S-42026-09-22S-40001140361-26-037334
SCHEDULE 13G2026-09-21—0001732748-26-000003
4252026-08-214250001193125-26-360063
8-K2026-08-211.01 Entry into a Material Definitive Agreement · 3.02 Unregistered Sales of Equity Securities · 7.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits0001193125-26-360059
8-K2026-08-201.01 Entry into a Material Definitive Agreement0001193125-26-359185
10-Q2026-07-3110-Q0001785530-26-000019
8-K2026-07-312.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits0001785530-26-000018
SCHEDULE 13D/A2026-07-02—0001346824-26-000187
SCHEDULE 13D/A2026-06-26—0001346824-26-000185
SCHEDULE 13D/A2026-06-22—0001346824-26-000180
SCHEDULE 13D/A2026-06-15—0001346824-26-000175
SCHEDULE 13D/A2026-05-14—0001346824-26-000131
SCHEDULE 13D/A2026-05-12—0001609492-26-000006
10-Q2026-05-0710-Q0001785530-26-000012
8-K2026-05-072.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits0001785530-26-000011
SCHEDULE 13D/A2026-05-05—0001609492-26-000004
10-K2026-03-2710-K0001785530-26-000006
8-K2026-03-272.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits0001785530-26-000005
32026-03-13FORM 30000905148-26-001247